Monthly extended-release risperidone (RBP-7000) in the treatment of schizophrenia

Authors

Anne Andorn, Indivior Inc.
Jay Graham, Indivior Inc.
John Csernansky, Northwestern University
John W. Newcomer, Washington University School of Medicine in St. Louis
Sunita Shinde, Indivior Inc.
Gilbert Muma, Indivior Inc.
Christian Heidbreder, Indivior Inc.
Maurizio Fava, Massachusetts General Hospital

Journal

Journal of Clinical Psychopharmacology

Publication Date

2019

Volume

39

Issue

5

First Page

428

Last Page

433

Document Type

Open Access Publication

DOI

10.1097/JCP.0000000000001076

Rights and Permissions

Andorn, Anne MD∗; Graham, Jay PharmD∗; Csernansky, John MD†; Newcomer, John W. MD‡; Shinde, Sunita MD∗; Muma, Gilbert PhD∗; Heidbreder, Christian PhD∗; Fava, Maurizio MD§ Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia, Journal of Clinical Psychopharmacology: 9/10 2019 - Volume 39 - Issue 5 - p 428-433 doi: 10.1097/JCP.0000000000001076 Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Recommended Citation

Andorn, Anne; Graham, Jay; Csernansky, John; Newcomer, John W.; Shinde, Sunita; Muma, Gilbert; Heidbreder, Christian; and Fava, Maurizio, "Monthly extended-release risperidone (RBP-7000) in the treatment of schizophrenia." Journal of Clinical Psychopharmacology. 39, 5. 428 - 433. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/9725